A Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of UCB0022 in Study Participants With Advanced Parkinson's Disease
Clinical trial NCT06055985 · COMPLETED
Trial details
- NCT number
- NCT06055985
- Sponsor
- UCB Biopharma SRL
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-17
- Primary completion
- 2025-03-31
- Enrollment
- 207
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.